A prize for the health organization that has the best plans to use and promote the FHIR International Patient Summary (IPS).
The Trillium II Prize will be awarded to the health organisation that, in the opinion of the panel of judges, has the best proposal to use, integrate and promote the HL7 FHIR International Patient Summary (IPS) for medical information exchange.
We are especially keen for Small to Medium Enterprises (SMEs) and not-for-profits to apply, although any organisation, other than members of the Trillium II consortium, can enter the competition. Partnerships may enter, though only if one organisation in the partnership accepts lead role.
What is FHIR IPS?
An International patient summary (IPS) is an electronic health record extract containing essential healthcare information intended for use in the unscheduled, cross-border (cross-jurisdiction) care scenario, comprising at least the required elements of the IPS dataset. The IPS dataset is a minimal and non-exhaustive patient summary dataset, specialty-agnostic, condition-independent, but readily usable by clinicians for the cross-border unscheduled care of a patient.
Trillium II | https://trillium2.eu/ | builds on European Commission recommendations on the Transformation of Health and Care, the EU-US Roadmap on eHealth Interoperability, and the recent EHRxF to put the IPS standards at the core of a global community of practice for digital health innovation. Trillium II bridges the gap between strategic intent and the capability to deliver interoperability at a global scale to advance patient safety and trust in digital health.
The competition will close on 1st May 2019 and the winners will be announced at an appropriate event in Europe a month thereafter. Furthermore, in addition to the promotional benefits from winning the prize, there will be a cash award of €1,000.
All the key documents relevant to the IPS that have been finalised to date are available for download.
A judging panel composed of international experts will select the winners:
Depending on the level of interest in the prize, a subcommittee of Trillium partners Alexander Berler, Catherine Chronaki, Charles Lowe and Janne Rasmussen may select a shortlist of entries for the above to judge.
Shortlist selection will be based on the following award criteria:
Registration and application details
All candidates are required to send a registration request to MedCom (Lene Taustrup, firstname.lastname@example.org) in order to ensure that they have immediate access to the online registration form and all the updates to the definition of the IPS, and other relevant data that are produced during the competition period, so that they are working from a level playing field. Entries should be in English only.
Successful submissions provide the information below in clearly identified sections: